Author

Kosta Stosic

Université Libre de BruxellesORCID 0009-0005-2984-034XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Christelle BouchartiD· 2 shared Julie NaveziD· 2 shared Laurine VersetiD· 2 shared Oier Azurmendi SenariD· 2 shared Pieter DemetteriD· 2 shared Rémy NicolleiD· 2 shared Tatjana ArsenijeviciD· 2 shared Vincent DetoursiD· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Christelle BouchartORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Glycation Stress-Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Pancreatic Cancer.

Oier Azurmendi Senar, Kosta Stosic, Christelle Bouchart, Julie Navez, Jawad Tarfouss, Rebekah Crake, Laurine Verset, Pieter Demetter, Marjorie Mauduit, Thierry Conroy, Jerome F. Cros, Rémy Nicolle, Manuel Saiselet, Joel Rodrigues Vitória, Vincent Detours, , Jean-Luc Van-Laethem

The paper develops a 16-gene signature (MG-GEM) that predicts survival benefit from adjuvant gemcitabine in resectable pancreatic cancer based on glycation stress, outperforming existing signatures.

bioRxiv · Jul 7, 2025 · PreprintCancer Biology

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy

Christelle Bouchart, Oier Azurmendi Senar, Julie Navez, Laurine Verset, Anaïs Boisson, Matthieu Hein, Kosta Stosic, Eric Quertinmont, Vjola Tafciu, Shulin Zhao, Léo Mas, Nicky D’Haene, Dirk Van Gestel, Luigi Moretti, Ilse Rooman, , Jean‐Luc Van Laethem

This study shows that combining FOLFIRINOX with stereotactic body radiotherapy remodels pancreatic ductal adenocarcinoma, improving stromal and metabolic features and prognosis.

bioRxiv · Apr 30, 2024 · PreprintCancer Biology